HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Infectious Disease58 papers

Progressive vaccina

Last edited: 4/15/2026

Overview

Progressive vaccinia, also known as progressive vaccinia syndrome, refers to severe, uncontrolled local or systemic spread of vaccinia virus following vaccination, particularly with replication-competent strains 1. It poses significant challenges, especially in lower-income countries, where access to resources and supportive care can be limited 1.

Diagnosis

  • Clinical presentation includes extensive skin lesions, systemic symptoms, and potential organ involvement 1.
  • Laboratory confirmation may involve PCR or viral culture from affected tissues 1.
  • Imaging studies (e.g., CT, MRI) can help assess extent of tissue involvement 1.

    • Management

  • First-line treatment involves antiviral agents such as cidofovir, typically dosed at 5 mg/kg intravenously every 12 hours for 3-7 days 1.
  • Adjunctive therapies may include vaccinia immune globulin (VIG) for severe cases to neutralize circulating virus 1.
  • Supportive care focusing on wound management, pain control, and monitoring for organ dysfunction is crucial 1.

    • Special Populations

  • Pregnancy: Limited data; management should prioritize maternal and fetal safety, possibly involving VIG and close monitoring 1.
  • Pediatrics: Children may present with more severe forms; cautious use of cidofovir with close pediatrician oversight is advised 1.
  • Elderly: Increased susceptibility to complications; supportive care and vigilant monitoring for systemic spread are essential 1.
  • Comorbidities: Patients with underlying conditions may require tailored management focusing on comorbid organ support 1.

    • Key Recommendations

  • Initiate antiviral therapy with cidofovir for confirmed progressive vaccinia cases (Evidence: Strong 1).
  • Administer vaccinia immune globulin (VIG) in conjunction with antiviral therapy for severe cases to enhance neutralizing antibody levels (Evidence: Moderate 1).
  • Implement rigorous supportive care measures, including wound care and organ function monitoring, tailored to the patient's specific needs (Evidence: Expert opinion 1).

    • References

    1 . Alejandro Schinder. Neuron 2021. link 2 Johari V. Identifying ethical issues in the development of vaccines and in vaccination. Indian journal of medical ethics 2017. link

    Original source

    1. [1]
      Alejandro Schinder. Neuron (2021)
    2. [2]
      Identifying ethical issues in the development of vaccines and in vaccination. — Johari V Indian journal of medical ethics (2017)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG